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Fragment- based drug design has emerged in the last dec-
ade. This exciting field has been recently reviewed [1].
Obtaining structural information on the fragment com-
plexed to the protein target is a key factor and also a major
limitation. Therefore, computational methods are needed
to mine efficiently all the available 3D structures of lig-
ands complexed to proteins, both treated as a whole and
as smaller fragment to increase the likelihood of fragment
hopping from one target to another.
MED-SuMo [2] is a target based drug design tool. This tool
is based on the identification of local shape and 3D Sur-
face Chemical Features similarities in the target binding
site with other proteins (with their co-crystallized lig-
ands). MED-SuMo uses the binding site of the target as a
query to search either the whole PDB (or any corporate
protein structure databank) for all the binding sites that
display a local match with the query. This valuable infor-
mation can then be used to identify which residues of the
binding site are potentially important for affinity and
selectivity. As the similar binding sites are overlaid, the co-
crystallized ligands are aligned and are therefore a starting
material for ligand hybridization. Among the hundreds of
overlaid binding sites generated by MED-SuMo, we found
the protein-ligand complexes overlaid by Pierce et al. [3]
for ligand hybridization in the BREED method. Interest-
ingly, they found relevant combinations of fragments
starting from only a few protein-ligand complexes struc-
tures and we believe that the output of MED-SuMo is a
very promising input for automatic methods like BREED.
In this work, we used MED-SuMo on a fragment database
derived from the PDB: each pdb file is converted into one
or more pdb files containing a single fragment as ligand.
MED-SuMo is used to query and mine the Surface Chem-
ical Functions surrounding the fragments, seeking similar-
ities with the protein of interest. A library of fragments
positioned in the active site and annotated with the
counts of contacts and h-bonds is generated. This is the
basis of a protocol which ranks and hybridizes fragments.
Fragmentation and hybridization steps are coupled with
substructure searches in a database of chemical com-
pounds from suppliers to increase the likelihood of frag-
ments and hybridized molecules as synthetically feasible
molecules.
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